Organon & Co. Common Stock (NY:OGN)

13.71 -0.01 (-0.04%)

Delayed Quote Updated: 2:13 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks ↗

June 29, 2023

These stocks are down more than 5% this year, and now may be a good time to add them to your portfolio.

Via The Motley Fool

Organon Publishes FY2022 ESG Report Showcasing Progress Toward Global Sustainability Goals

June 27, 2023

From Organon & Co.

Via Business Wire

Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts ↗

June 26, 2023

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields ↗

June 08, 2023

Via Benzinga

Organon's Return On Capital Employed Insights ↗

May 15, 2023

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

May 15, 2023

Via Benzinga

Organon's Earnings: A Preview ↗

May 03, 2023

Via Benzinga

Organon: Dividend Insights ↗

February 21, 2023

Via Benzinga

Organon and CAF, Development Bank of Latin America, Launch First-of-Its-Kind Collaboration to Increase Sustainable Financing in Women’s Health

June 07, 2023

From Organon & Co.

Via Business Wire

7 Stocks That Are Long Overdue for a Relief Rally ↗

May 18, 2023

Here are seven stocks with the catalysts and fundamentals to support a sustained relief rally in this environment.

Via InvestorPlace

Daily Stock Analysis: Organon & Co ↗

May 15, 2023

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions.

Via Talk Markets

Check Out 3 Health Care Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts ↗

May 09, 2023

Via Benzinga

Why Shares of Organon Fell 15% Thursday ↗

February 16, 2023

The company reported fourth-quarter and year-end financials.

Via The Motley Fool

Earnings Scheduled For February 16, 2023 ↗

February 16, 2023

Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year...

Via Benzinga

Earnings Preview For Organon ↗

February 15, 2023

Via Benzinga

Organon Reports Results for the First Quarter Ended March 31, 2023

May 04, 2023

From Organon & Co.

Via Business Wire

Organon To Report First Quarter and Host Conference Call on May 4, 2023

April 20, 2023

From Organon & Co.

Via Business Wire

7 Growth Stocks That Are Trading at a Bargain Price ↗

April 02, 2023

Some analysts suggest that equities are in the beginning of a bull market. If so, now is a good time to look at buying bargain growth stocks.

Via InvestorPlace

5 Value Stocks In The Healthcare Sector ↗

March 27, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023 ↗

March 16, 2023

Via Benzinga

Organon Launches “Her Plan is Her Power,” a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist

March 07, 2023

From Organon & Co.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

March 14, 2023

Tuesday's morning session saw 84 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 16, 2023

Via Benzinga

Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 16, 2023

Gainers TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash.

Via Benzinga

Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2022

February 16, 2023

From Organon

Via Business Wire

Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 16, 2023

February 06, 2023

From Organon & Co.

Via Business Wire

AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff ↗

January 31, 2023

Amgen launched its biosimilar knockoff on Tuesday at a steep discount.

Via Investor's Business Daily

'It's The Only China Stock I'd Buy': Cramer On This E-Commerce Stock ↗

January 26, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Alibaba Group Holding Limited (NYSE: BABA) is the only China stock he would buy.

Via Benzinga

Organon Stock Scores Market Leadership With Jump To 83 RS Rating ↗

January 17, 2023

Organon sees its Relative Strength Rating reach the 80-plus level.

Via Investor's Business Daily

Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy

January 05, 2023

From Organon & Co.

Via Business Wire

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.